Patent Assignment
Reel/Frame 012002/0763
Merger
Recorded: 2001-07-06
Pages: 12
Assignor
PHARMING B.V.
Executed: 1997-05-23
Assignee
PHARMING HOLDING N.V.
ARCHIMEDEWSWEG 4, 2333 CN LEIDEN, NETHERLANDS
Covered Property
(1)
Expression of Exogenous Recombinant Proteins from the Milk of Trans- Genic Mammals
Patent:
4,873,316 →
Application:
07/065,994 →
Related Assignments
(13)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 17, 1995
From: BIOGEN, INC.
To: GENE PHARMING EUROPE B.V.
Reel/Frame 007265/0408 →
Security Interest
Sep 21, 1998
From: PHARMING INTELLECTUAL PROPERTY BV
To: BIOGEN, INC.
Reel/Frame 009463/0419 →
Assignment of Assignor's Interest
Jan 17, 1999
From: BIOGEN, INC.
To: GENE PHARMING EUROPE B.V.
Reel/Frame 010188/0974 →
Change of Name
Feb 1, 2000
From: GENE PHARMING EUROPE B.V.
To: PHARMING B.V.
Reel/Frame 010589/0153 →
Grant of a Security Interest in Grantor's (Debtor'
Feb 27, 2006
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017223/0001 →
Assignment of Assignor's Interest
Mar 3, 2006
From: PHARMING HOLDING N.V.
To: PHARMING INTELLECTUAL PROPERTY B.V.
Reel/Frame 017240/0945 →
Grant of a Security Interest in Grantor's (Debtor's) Ownership Rights to Grantee (Secured Party)
Mar 3, 2006
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017251/0064 →
Release of Security Interest
Mar 2, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING INTELLECTUAL PROPERTY B.V.
Reel/Frame 024016/0536 →
Release of Security Interest
Mar 2, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING GROUP N.V.
Reel/Frame 024016/0452 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0151 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →